Pharmaceutical and medical device manufacturers

Interventions designed to drive positive patient outcomes and resonate with key stakeholders

By deploying adherence programmes that engage patients and stakeholders, pharmaceutical companies are able to enhance the clinical value of their products. They also evolve their value proposition from innovative providers of high-quality treatments to providers of healthcare solutions.

Supporting a range of product-life cycle management needs

Atlantis Healthcare offers a menu of patient support services to create a compelling value proposition across all stages of the product life-cycle:

• pre-marketing: to incorporate patient adherence measures during clinical trial and patient familiarisation phase;
• competitive marketing: to provide a point of differentiation at launch and during market growth phase;
• generic defence: to drive patient loyalty and defend market share; and
• OTC medicines: to provide unique brand differentiators and improve adherence.

Patient-centric design

The path to designing an effective patient adherence solution begins with understanding the patient's perspective on treatment and illness.

Our understanding is developed through an evidence-based framework; grounded in scientific approach and extensive clinical research. Our team of expert clinicians and psychologists are able to study the varying reasons for non-adherence and design programmes that target them at an individual patient level.

Our clinical and strategy teams ensure that our programmes are further reinforced through integration with key healthcare professionals, such as the prescribing and dispensing clinician.

Contact

Local office to discuss your brands needs with one of our solution strategists.